R
Raymond R. Townsend
Researcher at University of Pennsylvania
Publications - 706
Citations - 47086
Raymond R. Townsend is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Blood pressure & Kidney disease. The author has an hindex of 84, co-authored 673 publications receiving 39096 citations. Previous affiliations of Raymond R. Townsend include University of Texas Medical Branch & University of California, San Francisco.
Papers
More filters
Journal Article
Conversion of Urine Protein–Creatinine Ratio or Urine Dipstick Protein to Urine Albumin–Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis
Keiichi Sumida,Girish N. Nadkarni,Morgan E. Grams,Yingying Sang,Shoshana H. Ballew,Josef Coresh,Kunihiro Matsushita,Aditya Surapaneni,Nigel J. Brunskill,Steve Chadban,Alex R. Chang,Massimo Cirillo,Kenn B. Daratha,Ron T. Gansevoort,Amit X. Garg,Licia Iacoviello,Takamasa Kayama,Tsuneo Konta,Csaba P. Kovesdy,James P. Lash,Brian J Lee,Rupert W. Major,Marie Metzger,Katsuyuki Miura,David Naimark,Robert G. Nelson,Simon Sawhney,Nikita Stempniewicz,Mila Tang,Raymond R. Townsend,Jamie P. Traynor,Jose M. Valdivielso,Jack F.M. Wetzels,Kevan R. Polkinghorne,Hiddo J.L. Heerspink +34 more
TL;DR: In this paper, the authors present an analysis of the relationship between albuminuria and total urine protein or dipstick protein for chronic kidney disease (CKD) diagnosis and staging.
Journal ArticleDOI
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD
Xun Liu,Meredith C. Foster,Hocine Tighiouart,Amanda H. Anderson,Gerald J. Beck,Gabriel Contreras,Josef Coresh,John H. Eckfeldt,Harold I. Feldman,Tom Greene,L. Lee Hamm,Jiang He,Edward Horwitz,Julia B. Lewis,Ana C. Ricardo,Haochang Shou,Raymond R. Townsend,Matthew R. Weir,Lesley A. Inker,Andrew S. Levey,Lawrence J. Appel,Alan S. Go,John W. Kusek,James P. Lash,Akinlolu O. Ojo,Mahboob Rahman +25 more
TL;DR: Serum levels of low-molecular-weight proteins are affected by conditions other than GFR, and knowledge of these conditions can aid the interpretation of GFR estimates and risk using these markers and guide the use of these filtration markers in developing GFR estimating equations.
Journal ArticleDOI
Intravenous nicardipine for the treatment of severe hypertension. A double-blind, placebo-controlled multicenter trial.
J.David Wallin,Eugene Fletcher,C. Venkata S. Ram,M. Eileen Cook,Deanna G. Cheung,E. Paul MacCarthy,Raymond R. Townsend,Elijah Saunders,W. Ross Davis,Herbert G. Langford,George DeVault,Walter Flamenbaum,Gray Ellrodt,Bruce P. Hamilton,Stuart Frank,William H. Frishman +15 more
TL;DR: Patients with and without end-organ damage responded equally well to nicardipine treatment, and serious adverse experiences were infrequent, the most common adverse reaction being headache in 24% of the patients studied.
Journal ArticleDOI
Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension
TL;DR: A regimen of losartan alone or in combination with HCTZ was effective in treating patients with essential hypertension and was comparable to a regimen of enalaprilalone or in conjunction with hydrochlorothiazide, however, treatment withLosartan was associated with a lower incidence of cough.
Journal ArticleDOI
RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis
Anthony J. Saporita,Hsiang-Chun Chang,Crystal L. Winkeler,Anthony J. Apicelli,Raleigh D. Kladney,Jianbo Wang,Raymond R. Townsend,Loren S. Michel,Jason D. Weber +8 more
TL;DR: It is discovered that DDX5 is a key p53-independent target of the ARF tumor suppressor and is a novel non-oncogene participant in ribosome biogenesis.